Cargando…
Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci
One approach to combat the increasing incidence of multidrug-resistant (MDR) bacterial pathogens involves repurposing existing compounds with known safety and development pathways as new antibacterial classes with potentially novel mechanisms of action. Here, triclabendazole (TCBZ), a drug originall...
Autores principales: | Pi, Hongfei, Ogunniyi, Abiodun D., Savaliya, Bhumi, Nguyen, Hang Thi, Page, Stephen W., Lacey, Ernest, Venter, Henrietta, Trott, Darren J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398527/ https://www.ncbi.nlm.nih.gov/pubmed/34442776 http://dx.doi.org/10.3390/microorganisms9081697 |
Ejemplares similares
-
In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens
por: Pi, Hongfei, et al.
Publicado: (2022) -
Evaluation of Benzguinols as Next-Generation Antibiotics for the Treatment of Multidrug-Resistant Bacterial Infections
por: Nguyen, Hang Thi, et al.
Publicado: (2021) -
Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018) -
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018) -
In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens
por: Khazandi, Manouchehr, et al.
Publicado: (2019)